INTRODUCTION
Tumors have been traditionally regarded as biologically homogenous populations of cells endowed with high proliferating activity. This view is changing with the realization that many if not all cancers are organized as abnormal tissues containing a subset of cells with stem cell (SC)-like properties (cancer SCs), which produce differentiated progeny with limited replicative potential. Notably, cancer SCs are responsible for sustaining tumor growth in model systems and are thought to drive growth and metastasis of spontaneously occurring tumors (Clarke and Fuller, 2006; Zhang and Rosen, 2006) .
The notion of cancer SCs has important implications for cancer treatment. Current therapies have been developed to decrease tumor size and, though they may produce dramatic responses, are unlikely to result in long-term remissions if the rare cancer SCs are not targeted as well. A corollary of this view is that the selective ablation of cancer SCs should lead to the ''sterilization'' of the tumor and to its cure. There is, however, little experimental evidence in support of this concept, largely because of our scarce knowledge of cancer-SC specific biological and molecular mechanisms.
SCs are defined by their ability to generate more SCs (''selfrenewal'') and to produce cells that differentiate. These two tasks can be accomplished through a single self-renewing mitotic division (''asymmetric self-renewing division''), in which one progeny retains SC identity and the other (progenitor) undergoes multiple rounds of divisions before entering a postmitotic fully differentiated state. Two underlying mechanisms have been characterized in invertebrates: asymmetric partitioning of polarity and cell fate determinants, and asymmetric placement of daughter cells relative to external cues. The two cells generated by asymmetric divisions differ markedly in their proliferative potential: the SC remains quiescent or slowly proliferates, whereas the progenitor cell divides actively. This ensures the production of large numbers of differentiated progeny, while maintaining a relatively small pool of long-lived SCs (Morrison and Kimble, 2006) . SCs, however, possess the ability to expand in number, as occurs during development or, in the adult, after tissue injuries, a property that cannot be accounted by asymmetric divisions. Recent findings in invertebrates demonstrated that increased numbers of SCs can be achieved through rounds of ''symmetric self-renewing divisions,'' whereby each SC produces two new cells with identical SC fate and proliferation potential (Morrison and Kimble, 2006) .
Emerging evidence suggests that asymmetric division functions as a mechanism of tumor suppression in Drosophila neuroblasts. Loss-of-function mutations of cell polarity and cell fate determinants induce neuroblasts to divide symmetrically, leading to number increase, tissue overgrowth, and, ultimately, transplantable tumors that resemble mammalian cancers (Gonzalez, 2007) .
It is currently unknown whether in mammals there is also a direct causal relationship between loss of SC polarity and/or asymmetric division and tumor initiation. Unfortunately, the machinery that drives asymmetry of adult tissue SCs in mammals is largely uncharacterized, and whether self-renewing divisions are aberrantly regulated in cancer SCs is also unknown. Notably, some of the genes that control asymmetric cell divisions in fly have an evolutionarily conserved role in the regulation of cell polarity and in tumor suppression (Morrison and Kimble, 2006) , suggesting that polarity loss may contribute causally to cancer in mammals. Here, we report on our studies on the regulation of self-renewing divisions in cancer SCs of mammary tumors, chosen as a model of epithelial cancer in mammals.
RESULTS

Increased SC Numbers in ErbB2 Mammary Tumors
As mammary cancer model, we used ErbB2 transgenic mice, which express the activated ErbB2 oncogene in the mammary epithelium (Muller et al., 1988) . Transgenic ErbB2 mammary tumors follow a cancer SC model (Figure S1A available online) and recapitulate a frequent subtype of human breast cancers. To investigate the growth properties of SCs, we cultured primary cells from wild-type (WT) and tumor (ErbB2) mammary tissues in nonadherent conditions, which allow cells to proliferate in suspension as floating colonies (mammospheres) (Dontu et al., 2003) . Their preliminary characterization revealed that, as reported, WT and ErbB2 tumor mammospheres derive from the clonal expansion of single cells endowed with self-renewal potential, are composed of epithelial cells, and are enriched in multipotent cells capable of differentiating along different lineages (Figures S1B-S1E).
To determine numbers of SCs in mammospheres, we performed limiting dilution transplantation of cell suspensions from WT or ErbB2 tumor secondary (M2) mammospheres into cleared fat pads or mammary glands of syngeneic mice, respectively (from 10 5 to ten cells). Histology revealed that the epithelial outgrowths obtained with WT mammospheres were morphologically indistinguishable from the normal mammary gland and contained both luminal (cytokeratin 8 positive) and basal/myo-epithelial (cytokeratin 5 positive) cells ( Figure 1A ). Likewise, tumors obtained with the ErbB2 tumor mammospheres were indistinguishable from primary tumors ( Figure 1B ). The calculated frequency of SCs was $1:300 in the WT mammospheres (Table 1) . Since the average size of WT M2 mammospheres was $360 (362 ± 14; n = 15), the expected frequency of SCs was approximately 1 in WT mammospheres (confirmed by limiting dilution transplantation of intact mammospheres; Table 1 ). In the ErbB2 tumor mammospheres, instead, the frequency of SCs was $1:100 (Table 1) , which predicts approximately 5 SCs per sphere (average size 522 ± 14; n = 13). Notably, the transplantation efficiency of WT and ErbB2 tumor M2 mammospheres (0.31% and 1.05%) was similar to their sphere forming efficiency (SFE) (0.15% and 0.95%). Thus, ErbB2 tumor mammospheres contain increased numbers of SCs. To investigate whether also ErbB2 primary tumors contain increased numbers of SCs, we performed limiting dilution transplantation of primary cells from normal or tumor mammary glands. The calculated frequency of SCs in the normal mammary gland was $1:30,000 (Table 1 and Figure S2A ), consistent with recent reports using fractionated mammary cells (Table S1 ). The calculated frequency of SCs was instead $1:4000 in the ErbB2 tumors (Tables 1 and S2 and Figure S2B ), indicating that the number of SCs is increased in ErbB2 tumor tissues.
Increased Self-Renewal of ErbB2 Tumor Mammary SCs
To investigate whether increased numbers of SCs in the ErbB2 tumor mammospheres were due to increased frequencies of self-renewing divisions, we purified different mammosphere cell subsets according to their proliferation history (using PKH-26) and then investigated their SC identity by mammosphere formation and transplantation assays. PKH-26 is a fluorescent dye that binds to cell membranes and segregates in daughter cells after each cell division, such that intensity of staining correlates inversely, at single cell level, with the number of previous cell divisions (Lanzkron et al., 1999) .
Primary mammary cells from WT mice were stained ex vivo with PKH-26 and cultured to obtain primary (M1) and M2 mammospheres ( Figure S1F Figure 1D ). To analyze SC frequencies in the PKH subsets, we performed limiting dilution transplantations. Strikingly, injection of cell dilutions corresponding to one PKH high cell reconstituted the cleared fat pad in ten out of 26 injections, while no mammary reconstitution was observed with up to 10 5 PKH low , PKH neg , or PKH low+neg cells ( Figure 1E ), indicating that PKH high cells are highly enriched in mammary SCs ($1:3) and the sole cell subset capable of reconstituting the mammary gland (Table 1) . Notably, PKH high cells could be serially transplanted ( Figure 1F ) and coexpressed the mouse mammary SC-specific markers CD49f and CD24 (Figure S3 ), i.e. they contain bona fide mammary SCs. Thus, cells with the lowest proliferation potential are the sole ones, within WT mammospheres, with self-renewal activity in vitro and in vivo, suggesting that WT mammary SCs undergo limited self-renewing divisions.
In Figure 1G ). Together, these data demonstrate that, within the ErbB2-mammospheres, SCs undergo increased numbers of self-renewing divisions.
Increased Symmetric Divisions of ErbB2 Tumor Mammary SCs
Increased numbers of self-renewing divisions do not necessarily result into increased numbers of SCs, if they are accomplished through asymmetric mitotic divisions. We investigated modes of self-renewing divisions by time-lapse video microscopy. PKH high cells from M2 mammospheres were seeded in methylcellulose and monitored for 7 days, at 1 hr intervals (same SFEs in methylcellulose or liquid culture; Figure S1G ). Only PKH high cells that formed a full-sized mammosphere at the end of the incubation time (mammosphere-initiating cells [MICs] ) were considered in the analysis. The first division was defined as asymmetric if one of the first-generation daughter cells remained quiescent, whereas the other divided further, giving rise to a total of five cells by day 3. It was defined as symmetric when both daughter cells continued to divide, giving rise to eight cells with dim fluorescence at 3 days ( Figure 2A ). In the WT PKH high MICs, the first division (42 ± 8.2 hr after seeding) was asymmetric in the majority of cases (80.4%; n = 103). Of the remaining, it was symmetric in 7.8% and in 11.8% could not be defined. Based on the observed inverse correlation between proliferation potential and SC fate during mammosphere growth, these findings suggest that the replicative asymmetry of WT MICs generates daughter cells with different developmental fate.
We thus investigated whether replicative asymmetry correlates with asymmetric partitioning of cell fate determinants, analyzing the intracellular localization of Numb after the first mitotic division in WT PKH high cells. Specificity of anti-Numb staining in mammospheres was confirmed by RNA interference ( Figure S4 ). To analyze Numb distribution immediately after mitosis, we treated PKH high cells with blebbistatin, a small molecule that arrests cytokinesis and leads to the formation of binucleated cells (Straight et al., 2003) . In $60% (n = 82) of the WT PKH high cells, the anti-Numb staining was weakly cytoplasmic and formed a clear crescent at the cell membrane, whereas in $25% Numb was uniformly localized around the cell cortex ( Figures 2B and S5 ). Together, these data demonstrate that the first mitotic division of WT PKH high cells is most frequently asymmetric. In contrast, time-lapse and Numb localization analyses of ErbB2 tumor PKH high cells revealed symmetry of the first division (42.1 ± 6.2 hr after seeding) in 78.2% of cells (n = 156; Figure 2A ) and uniform distribution around the cortex in 74.5% (n = 47; Figures 2B and S5 ). Altogether, these findings suggest that 
Increased Replicative Potential of ErbB2 Tumor SCs
We then investigated the replicative potential of WT and ErbB2 tumor SCs by serial replating of M1 mammospheres. In WT cultures, the total number of mammospheres decreased progressively at each passage, until exhaustion after five to six passages ( Figure 3A ). The cumulative mammosphere number approximated an exponential curve (R 2 = 0.99) with a growth rate (GR) of $0.3, indicating a similar decrease rate ($70%) at each passage. Notably, total cell number revealed identical patterns of variation (GR $0.3; Figure 3B ). Accordingly, the average size of WT mammospheres remained constant throughout the passages ( Figure 3C ), thus suggesting that WT SCs, once committed to clonal expansion, maintain the same growth potential.
The number of ErbB2 tumor mammospheres instead increased at every passage, with a constant $5-fold expansion (GR $5; Figures 3A and 3B ), suggesting that ErbB2 tumor SCs are nearly immortal (up to 36 passages in selected experiments). As for the WT mammospheres, the total cell number revealed identical patterns of variation, with a GR of $5 and constant mammosphere size during culture ( Figures 3B and 3C) .
Together, these findings demonstrate that WT SCs rapidly lose self-renewal potential in culture, whereas ErbB2 tumor SCs are nearly immortal, and suggest that these different behaviors reflect intrinsic properties of WT and ErbB2 tumor SCs. Furthermore, these data suggest that the two observed Correlation between ErbB2 Levels and Self-Renewal Potential of Mammary SCs We wondered whether alterations of the self-renewal properties of ErbB2 tumor SCs were the consequence of ErbB2 expression. Thus, we examined SC self-renewal in premalignant mammary glands of ErbB2 transgenic mice of different age. Expression of ErbB2 was first detected at 6 weeks of age, in the apparently normal mammary gland, and increased progressively with the appearance of histological signs of tumor progression: hyperplasia, in situ ductal carcinomas (DCIS), and invasive tumors ( Figures S6A and S6B ). The replicative potential of mammospheres derived from the apparently normal mammary glands of ErbB2 transgenic mice decreased progressively during passages ( Figure S6C ), as expected (GR = 0.61). In contrast, mammospheres derived from the hyperplasic, DCIS, and tumoral mammary glands did not lose replicative potential upon serial replating ( Figure S6C ). GR, however, differed significantly among the three samples ($1.1, $2.5, and $4.8, respectively; Figure S6D ). Together, these results show a direct correlation between levels of ErbB2 transgene expression and replicative potential of mammary SCs, suggesting that ErbB2 increases self-renewal. We cannot exclude, however, that accumulating genetic alterations cooperate with ErbB2 to determine the phenotypic changes of ErbB2 tumor SCs.
Increased Frequency of Symmetric Divisions and Replicative Potential of p53 Null SCs
To investigate underlying molecular mechanisms, we analyzed expression of genes implicated in self-renewal regulation and found increased expression of Nanog ( Figure 3D ), a transcription factor that regulates self-renewal in embryonic stem cells (ESCs), in ErbB2 tumor mammospheres. Notably, Nanog expression is downregulated by the tumor suppressor p53 during ESC differentiation (Lin et al., 2005) and is increased in mammospheres from the p53 À/À mammary epithelium ( Figure 3D ). p53 was reported to impose an asymmetric proliferative fate in fibroblasts and epithelial cells (Rambhatla et al., 2001) . To investigate frequency and modes of self-renewing divisions in p53
SCs, primary cells from the premalignant p53 À/À mammary gland were analyzed with the PKH-26 assay. As in the WT and ErbB2 tumor cultures, PKH pos cells were >99% after the initial staining and $60% in the M2 mammospheres. FACS-sorted PKH high , PKH low , and PKH neg subsets were all capable of sphere formation, though with decreasing frequency ($60%, $1%, and <1%, respectively; Figure 3E ). Time-lapse microscopy of PKH high cells showed high proportions of symmetric divisions (74.9%; n = 190; Figure 2A ). Strikingly, Numb was weakly cytoplasmic and uniform around the cortex in the majority of the p53 À/À PKH high cells (74.4%; n = 43; Figures 2B and S5 ), suggesting that p53 regulates polarity of cell division in mammary SCs. Thus, like ErbB2 tumor SCs, p53 À/À mammary SCs undergo increased numbers of self-renewing divisions, mainly of symmetric type, during mammosphere expansion. Serial replating experiments showed that p53 À/À mammospheres increased in number at every passage (GR $5, identical to that of the ErbB2 tumor mammospheres; Figure 3F ) and could be propagated continuously. Similar results were obtained after RNA interference of p53 in WT mammospheres ( Figure S7A Figure S2C ) and by the 5-bromo-2 0 -deoxyuridine (BrdU)-label retaining assay ( Figure S2D ). Thus, p53 À/À mammospheres and mammary glands also contain increased numbers of SCs.
Finally, we examined whether the frequency of SCs in the mammary gland of p53 À/À mice increased over time, using the mammosphere assay. As shown in Figure 3H , the number of MICs in the mammary glands of 4-, 6-, or 9-week-old p53 À/À mice was higher than in WT controls at any time point, and increased progressively, following an apparently geometric pattern of expansion (104 ± 10, 225 ± 32, and 483 ± 148). Altogether, these data demonstrate that p53 regulates self-renewal of mammary SCs and that loss of p53 favors their continuous expansion, in vitro and in vivo.
Reduced Symmetric Divisions and Replicative Potential of ErbB2 Tumor SCs after p53 Restoration In Vitro
The p53 gene is not mutated in ErbB2 transgenic tumors (data not shown). p53 activity, however, is frequently attenuated in tumors carrying WT p53, including mammary tumors, because of alterations of genes that control p53 activation. Thus, we analyzed DNA damage-induced p53 activation in ErbB2 tumor mammospheres. p53 was low or undetectable in untreated WT or ErbB2 cells and accumulated between 4 and 8 hr after treatment, when its phosphorylation was also evident. The extent of p53 stabilization and phosphorylation was, however, as the ratio of counted spheres to plated cells multiplied by the number of freshly isolated cells obtained per each gland pair. Data are expressed as mean ± SD of the number of MICs for mammary gland (data from the third or fourth pair of mammary glands were pooled).
(I) p53 response in WT and ErbB2 tumor mammospheres. Cells from M1 mammospheres were treated with adriamycin (2 mg/ml) or UV rays (50 J/m 2 ) 2 days after replating and collected at the indicated time points. Levels of p53 and extent of p53 serine-18 phosphorylation were analyzed by western blotting with specific antibodies. Numbers above the blots refer to the densitometric analysis of the anti-p53 and anti-phS18p53 signals normalized against the corresponding antivinculin values and expressed (at each time point) as ErbB2/WT ratio. A representative blot of three independent experiments that gave similar results (t test in Figure S8 ) is shown.
significantly reduced in the ErbB2 tumor samples ( Figures 3I and  S8 ). Thus, p53 signaling is attenuated in mammospheres derived from ErbB2 tumors. To investigate whether partial inactivation of p53 is responsible for the increased self-renewal of ErbB2 tumor SCs, we overexpressed p53 in ErbB2 tumor mammospheres. p53-overexpressing mammospheres, however, showed only a modest yet statistically significant decrease in number during serial passages ( Figure S7B ), suggesting the presence, in these cells, of active mechanisms of p53 inhibition. Notably, ErbB2 overexpression was reported to induce downregulation of p53 in mammary epithelial cells (Zheng et al., 2004) . Thus, we decided to restore p53 function with Nutlin3 (N3), a small molecule that induces p53 stabilization by inhibiting MDM2-dependent p53 degradation (Vassilev et al., 2004) . M1 WT and ErbB2 mammospheres were disaggregated and replated to obtain M2 mammospheres, in the presence of increasing concentrations of N3. Western blots showed increased p53 levels in both WT and ErbB2 tumor samples ( Figure 4A, upper panels) . QRT-PCR analysis of Nanog RNA expression revealed an $3-fold reduction in the ErbB2 tumor cells ( Figure S9A) . Surprisingly, however, N3 did not induce apoptosis ( Figure S9B ), nor it exerted significant effects on the number or size of M2 WT or ErbB2 tumor mammospheres ( Figure 4B ).
We then investigated the effects of N3 on the frequency of self-renewing divisions by measuring numbers of SCs in WT or ErbB2 tumor M2 mammospheres at the end of a 6 day treatment. N3-treated M2 mammospheres were replated in the absence of Five thousand cells from M1 mammospheres were plated in quadruplicates in the presence of increasing concentrations of N3 (0.1-10 mM) to obtain M2 mammospheres. After 6 days of culture, M2 mammospheres were counted and disaggregated, so that the total cell number could be counted. Sphere size was calculated as ratio between cell number and number of mammospheres. Five thousand cells from M2 mammospheres were replated in the presence or absence of N3 to obtain M3 mammospheres. N3 to obtain M3 mammospheres. In the M3 mammospheres, p53 levels returned to basal levels in both WT and ErbB2 tumor samples ( Figure 4A , lower panels). Strikingly, while the number of WT M3 mammospheres was comparable to that of untreated controls at all drug concentrations, that of ErbB2 tumor M3 mammospheres was markedly reduced ($14 folds with 10 mM N3; Figure 4C , upper panel). Notably, absolute numbers were comparable, at the highest concentrations of N3 (2.5, 5, and 10 mM) to those of untreated WT M3 mammospheres (Figure S9C) . Again, N3 treatment did not affect the size of WT or ErbB2 tumor mammospheres ( Figure 4C , lower panel). Reseeding of N3-treated M2 mammospheres in the presence of N3 did not further decrease the number or size of M3 mammospheres in either WT or ErbB2 tumor samples ( Figure 4D ), despite high levels of p53 protein (data not shown). Finally, N3 exerted no effect on the growth of p53 À/À mammospheres, showing the absence of off-target effects ( Figures 4B and 4C ).
Together, these results demonstrate that N3 induces p53 stabilization in both WT and ErbB2 tumor mammospheres and reduces the frequency of self-renewing divisions only in the latter. This is consistent with our observation that p53 directs asymmetric divisions in mammary SCs and suggests that N3 reduces the frequency of self-renewing divisions selectively in ErbB2 tumor SCs by switching their mode of division from symmetric to asymmetric, without affecting cell viability. To demonstrate it directly, we evaluated the effects of N3 treatment on the frequency of symmetric/asymmetric divisions of ErbB2 tumor SCs by time-lapse microscopy. The first division of N3-treated ErbB2 tumor PKH high cells was asymmetric in the majority of cases (70.5%; Figure 2A) .
We next investigated the effects of N3 treatment on mammosphere replicative potential, by serial replating ( Figure 4E ). Increasing N3 concentrations had little effect on the growth of WT mammospheres, whereas they progressively reduced that of ErbB2 tumor mammospheres. At the highest N3 concentrations, ErbB2 tumor mammospheres exhausted, similarly to untreated WT samples. N3 exerted no effect on the replicative potential of p53 À/À mammospheres. In conclusion, N3 reversed both properties of ErbB2 tumor SCs to divide symmetrically and extensively.
Reduced SC Numbers and Tumor Size after p53 Restoration In Vivo First, we investigated the effects of N3 on the ability of ErbB2 tumor mammospheres to form tumors in vivo. Cell suspensions from N3-or dimethyl sulfoxide (DMSO)-treated M2 mammospheres were analyzed by western blotting to monitor p53 stabilization ( Figure 5A ) and transplanted in the absence of further N3 treatment. After 8 weeks, the size of tumors originated from the N3-treated ErbB2 tumor mammospheres was $8-fold smaller ( Figure 5B ), in the absence of significant differences in the frequency of proliferating (Ki-67 positive) or apoptotic (caspase3 positive) cells ( Figure 5C and data not shown).
We then investigated the effects of N3 on spontaneous ErbB2 tumors. Two-month-old ErbB2 transgenic mice were treated with N3 or DMSO for 2 weeks (one intraperitoneal injection every 2 days). One group of mice was sacrificed at the end of the treatment to measure SC numbers (by transplantation), and a second group was sacrificed after 2 months to measure tumor size. N3 treatment decreased SC numbers to WT levels (Table 1) without altering proliferation or viability of bulk tumor cells ( Figure 5D ) and decreased tumor size by approximately 3-to 4-fold ( Figure 5E ). Notably, N3 had no detectable effects on WT mammary glands (Table 1 and Figure 5D ). Thus, N3 treatment reduced the frequency of tumor SCs and delayed tumor growth, with negligible antiproliferative effects on additional cancer cells, suggesting that the increased self-renewal of ErbB2 tumor SCs contributes to tumor growth in vivo.
DISCUSSION Symmetric Divisions and Increased Numbers of Cancer SCs
We have demonstrated that the PKH-26/mammosphere assay allows for the isolation to near purity of bona fide mammary SCs. Direct imaging of the initial self-renewing division of WT SCs revealed that, in most cases, it generates two daughter cells with different proliferative fates: one that is quiescent and another that proliferates actively. Evaluation of the correlation between proliferation potential and SC fate during mammosphere growth showed that the less proliferating cell subset (PKH high ) was highly enriched in SCs (one out of three) and the only subset containing SCs, suggesting that the observed replicative asymmetry of WT SCs generates daughter cells with different developmental fate. This was confirmed by analysis of the intracellular localization of the cell fate determinant Numb after the first mitotic division of WT PKH high cells, which showed that cell divisions are intrinsically asymmetric. The behavior of the ErbB2 tumor MICs was remarkably different: each produced two cells with identical proliferation potential and uniform distribution of the cell fate determinant Numb. In the formed mammosphere, SCs were found also within the most proliferating cell subset (PKH neg ), indicating that they underwent multiple rounds of cell divisions without losing self-renewal potential. Thus, one relevant feature of cancer SCs is their acquired property to divide symmetrically and, as consequence, to increase their numbers. Consistently, we found that during clonal expansion in vitro (as occurs during mammosphere formation) cancer SCs increase in number, whereas WT SCs do not, and that primary tumors contain increased numbers of SCs.
Alternate Usage of Asymmetric versus Symmetric Divisions in Cancer SCs
Though increased in numbers, the ErbB2 tumor SCs remain minor cell subpopulations within cultured mammospheres or in the primary tumors, which are mainly composed of SC progenies at different stages of differentiation. These observations imply that ErbB2 tumor SCs can increase in number without, however, losing their developmental potential. In principle, this can be achieved, in a pool of SCs, by the alternate use of symmetric and asymmetric divisions. This is consistent with our observation that cancer SCs could divide either asymmetrically or symmetrically, though with inverted relative frequencies as compared to WT SCs. We noticed, however, an apparent discrepancy between the numbers of SCs found in the formed ErbB2 tumor mammosphere (5-8; $1%) and the theoretical number ($400; $80%) that is obtained if one assumes that the frequency of symmetric divisions of the mammosphere-initiating cells ($80%) remains the same during its expansion in the growing mammosphere. Notably, the frequency of SCs in the primary ErbB2 tumors is even lower than in the formed mammosphere (<0.1%). To address this issue, we modeled the proliferative history of SC proliferation during mammosphere formation.
The resulting model (Figure 6 ) indicates that the relative frequency of symmetric divisions adopted by ErbB2 tumor SCs decreases progressively during mammosphere growth, suggesting that the mammosphere or the tissue environments, through as yet unidentified mechanisms, influence the binary fate decision of mammary ErbB2 tumor SCs in favor of the asymmetric divisions.
Extended Replicative Potential of Cancer SCs
Although SCs have an enormous self-renewal capacity, there is evidence that the number of times that a SC replicates is restricted, suggesting that self-renewal of SCs is intrinsically limited. In fact, WT mammary SCs rapidly lose self-renewal potential in culture (data not shown), and the whole mammary tissue can be serially transplanted less than six to seven times (Daniel et al., 1968) . On the contrary, ErbB2 tumor SCs are nearly immortal, and the potential of ErbB2 tumors to be serially transplanted is virtually unlimited. Thus, extended replicative potential, together with increased frequency of symmetric divisions, might be responsible for the continuous and geometric expansion of cancer SCs. ErbB2 tumor SCs, however, can also divide asymmetrically, a property that might account for their ability to originate differentiated progeny, thus maintaining tumor cell heterogeneity and leading to the continuous expansion of the tumor mass.
Regulation of SC Polarity by p53
Like the ErbB2 tumor SCs, p53 null SCs are near immortal in culture and undergo symmetric self-renewing divisions, two properties that are consistent with their ability to expand geometrically in culture. Most notably, in the mammary gland of p53 null mice, numbers of SCs are increased and expand progressively over time, thus indicating that p53 null SCs divide symmetrically also in vivo. It has been reported that the mammary epithelium of mice with increased WT p53 activity (p53 +/m mice) has decreased regenerative capabilities upon serial transplantation, suggesting early stem cell exhaustion (Gatza et al., 2008) . Together, these data suggest that one physiological function of p53 is to maintain a constant number of SCs in the mammary gland by imposing an asymmetric mode of selfrenewing divisions. Interestingly, loss of p53 increases selfrenewal of neural SCs (Meletis et al., 2006) , suggesting that this might represent a general function of p53 in SCs of different tissues. The molecular mechanisms underlying this effect of p53 on self-renewal are unclear. We found increased levels of Nanog expression in both p53 À/À and ErbB2 tumor mammospheres, which were reverted after N3 treatment. RNA interference of Nanog expression in p53 À/À or ErbB2 tumor mammospheres, however, did not affect their growth kinetics, suggesting that, in this system, p53 role in self-renewal is independent of Nanog (P.G.P., unpublished data).
Loss of p53, Increased Frequency of Symmetric Divisions, and Tumor Initiation A role for p53 loss in mammary carcinogenesis is suggested by the high proportion of breast cancers with p53 mutations and the prevalence of breast tumors in women with germline mutations of p53. Although the mammary gland of p53 null mice is apparently normal (Jerry et al., 1998) and p53 null mice rarely develop mammary tumors (probably because of the early occurrence of lymphomas), high incidence of mammary tumors develops after somatic inactivation of p53 (Liu et al., 2007) or transplantation into WT fat pads of the p53 null mammary epithelium Kuperwasser et al., 2000) . Thus, the p53 null mammary epithelium contains increasing numbers of SCs and is highly susceptible to tumor development, suggesting that increased frequency of symmetric divisions might contribute to mammary tumorigenesis in the p53 null mice by expanding the pool of putative tumor target cells. Notably, the mammary gland mass, which is likely to correlate with the number of mammary SCs, is an important breast cancer risk factor (Trichopoulos et al., 2008) . Since p53 is a potent suppressor of mammary transformation, an intriguing possibility is that inhibition of SC symmetric divisions by p53 is one mechanism of tumor suppression in the mammary epithelium.
Loss of p53, Increased Frequency of Symmetric Divisions, and Tumor Growth We found that p53 signaling is attenuated in the ErbB2 tumor mammospheres and that restoration of p53 by N3 provokes the rapid exhaustion of cultured mammospheres and reduces tumor growth in vivo. Analysis of biological mechanisms suggests that the antitumor activity of N3 is due to a selective effect of the drug on the self-renewing divisions of ErbB2 tumor SCs. First, N3 converted the prevailing mode of division of ErbB2 tumor SCs from symmetric to asymmetric. Consistently, the frequency of ErbB2 tumor SCs decreased dramatically in cultured mammospheres and primary tumors after N3 treatment. Furthermore, N3 did not induce apoptosis in either ErbB2 mammospheres or primary tumors, nor did it reduce the fraction of proliferating cells. Together, these data imply that increased frequency of symmetric divisions and extended replicative potential of ErbB2 tumor SCs contribute to tumor growth in vivo.
Therapeutic Efficacy of p53 Restoration in Cancer SCs
Three groups have recently reported that re-expression of p53 causes regression of different p53 null tumors, including lymphomas, sarcomas, and hepatocellular carcinomas (Martins et al., 2006; Ventura et al., 2007; Xue et al., 2007) . We show that this can be achieved also with drugs that target p53 in tumors carrying WT p53 alleles and attenuated p53 signaling, a situation that is common to $50% of human cancers. Our findings, however, suggest that restoration of p53 by N3 selectively affects the self-renewal of cancer SCs. This is surprising, since re-expression of p53 in p53 null tumors promoted senescence or apoptosis (depending on the tumor cell type) and a rapid reduction of the tumor mass (within days). To resolve this issue, it would be important to determine treshold and targets (cellular or molecular) of p53 restoration in different tumor types.
EXPERIMENTAL PROCEDURES Mammosphere Cultures and Mouse Studies
Mammosphere cultures and transplantation assays were performed as described (Dontu et al., 2003; Sleeman et al., 2006) (also see the Supplemental Experimental Procedures). Outgrowths were quantified as percent of fat pad filling after whole mount analysis (range, 25% to 80%). Nutlin3 was either purchased from Cayman Chemicals or generously supplied by M. Varasi (Department of Chemistry, DAC s.r.l., Milan, Italy) and prepared as previously reported (patent WO2003051359A1, 2003) , apart from the synthesis of intermediate meso-1,2-bis-(4-chloro-phenyl)-ethane-1,2-diamine (Kise and Ueda, 2001 ).
PKH26 Assay
Primary mammary cells were stained for 5 min with 1:250 PKH-26 dye (Sigma), blocked with 1% BSA, washed twice, and plated to obtain primary and M2 mammospheres. Single-cell suspensions from M2 mammospheres were FACS sorted with a FACS Vantage SE flow cytometer (Becton & Dickinson) equipped with a 488 nm laser (Enterprise Coherent) and a band-pass 575/ 26 nm optical filter (FL2 channel). An average sorting rate of 1000 events per second at a sorting pressure of 20 PSI was maintained.
Intracellular Localization of Numb PKH high cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and 3% BSA and stained with anti-Numb (Colaluca et al., 2008) followed by anti-mouse Alexa 647 (Jackson Laboratories) antibodies.
Confocal analysis was performed with a Leica TCS SP2 AOBS microscope. For each cell, 15-20 adjacent 0.5 mm optical sections were collected.
Time-Lapse Microscopy
Time-lapse microscopy was performed with a Scan R screening station (Olympus-SIS) equipped with a microscope incubation chamber (Evotec). Five hundred to 1000 PKH high cells were resuspended in Methyl Cellulose in complete medium, plated in glass bottom dishes, and observed through a 10 3 0.4 NA objective. Both DIC and PKH red fluorescence images were collected with auto-focusing procedures and compensated for focal shift. Different focal planes were recorded to prevent loss of image contrast due to axial cell movement. Images were captured every hour for 7 days, starting 14 hr after plating, and reconstructed with ImageJ software.
Statistics
Limiting dilution data were analyzed with the ''statmod'' software package for the R computing environment (http://www.r-project.org/). SC frequencies were estimated by a complementary log-log generalized linear model. Twosided 95% Wald confidence intervals were computed. In cases of zero outgrowths, one-sided 95% Clopper-Pearson intervals were computed. The single-hit assumption was tested as recommended (Bonnefoix et al., 1996) and was not rejected for any dilution series (p > 0.05).
Western Blot, Immunohistochemistry, and QRT-PCR Analysis See the Supplemental Experimental Procedures.
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